| 0.181 0.002 (1.12%) | 05-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.26 | 1-year : | 0.3 |
| Resists | First : | 0.22 | Second : | 0.25 |
| Pivot price | 0.18  |
|||
| Supports | First : | 0.16 | Second : | 0.13 |
| MAs | MA(5) : | 0.17  |
MA(20) : | 0.19 |
| MA(100) : | 0.3 |
MA(250) : | 0.66 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 16.1 |
D(3) : | 13.9 |
| RSI | RSI(14): 33 |
|||
| 52-week | High : | 2.51 | Low : | 0.16 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VSEE ] has closed above bottom band by 32.5%. Bollinger Bands are 50.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.18 - 0.18 | 0.18 - 0.18 |
| Low: | 0.17 - 0.17 | 0.17 - 0.17 |
| Close: | 0.18 - 0.18 | 0.18 - 0.18 |
VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Wed, 01 Apr 2026
VSee Health reports 40% revenue growth for 2025 - Investing.com
Wed, 01 Apr 2026
Large hospital contracts drove VSee's 40% revenue growth in 2025 - Stock Titan
Tue, 31 Mar 2026
VSee Health 2025 10-K: Revenue $14.6M, Loss per Share $(0.73) - TradingView
Tue, 24 Mar 2026
VSee Health (VSEE) CFO granted quarterly stock awards as compensation - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 47 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 16.7 (%) |
| Held by Institutions | 13.5 (%) |
| Shares Short | 784 (K) |
| Shares Short P.Month | 1,400 (K) |
| EPS | -0.74 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.34 |
| Profit Margin | -100.7 % |
| Operating Margin | -87.7 % |
| Return on Assets (ttm) | -28.3 % |
| Return on Equity (ttm) | -541.6 % |
| Qtrly Rev. Growth | 5 % |
| Gross Profit (p.s.) | 0.15 |
| Sales Per Share | 0.3 |
| EBITDA (p.s.) | -0.15 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -0.25 |
| PEG Ratio | 0 |
| Price to Book value | -0.54 |
| Price to Sales | 0.57 |
| Price to Cash Flow | -2.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|